Seattle Genetics Inc (NASDAQ:SGEN)

49.57
Delayed Data
As of 4:00pm ET
 -1.22 / -2.40%
Today’s Change
45.31
Today|||52-Week Range
71.32
-7.35%
Year-to-Date
No recent news for Seattle Genetics Inc.

Today’s Trading

Previous close50.79
Today’s open50.72
Day’s range49.48 - 50.96
Volume767,265
Average volume (3 months)1,096,043
Market cap$9.0B
Data as of 4:00pm ET, 04/19/2018

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)-78.71%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+15.33%
P/E ratioNM
Price/Sales15.88
Price/Book12.19

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc-2.32-4.25%
ALKSAlkermes Plc-0.70-1.49%
ALNYAlnylam Pharmaceutic...-1.51-1.55%
IONSIonis Pharmaceutical...-0.18-0.39%
Data as of 4:00pm ET, 04/19/2018

Financials

Next reporting dateApril 27, 2018
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$482.3M
Annual profit (last year)-$125.5M
Net profit margin-26.03%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
CFO &
Principal Accounting Officer
Todd E. Simpson
Corporate headquarters
Bothell, Washington

Forecasts